OSBPL3 and colorectal carcinoma: To further validate OSBPL3 promotes progression of CRC through activation of the RAS pathways, we examined the growth and invasion ability of OSBPL3-overexpressed RKO cells after inhibition of this pathway using GGTI-2133.